Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Global investors are poised for a pivotal week focused on corporate earnings—particularly in artificial intelligence sectors—and the Federal Reserve's interest rate stance. This follows recent market volatility triggered by political disputes involving U.S. Greenland acquisition attempts and trade concerns with Europe. While major indexes have reco…
Jefferies has raised its price target on Columbia Banking System to $32 from $30 while maintaining a Hold rating, following the bank's slightly better than expected fourth-quarter results and mixed guidance for fiscal year 2026. The bank’s net interest income and core earnings per share surpassed analyst expectations, bolstered in part by acquisiti…
Raymond James has increased its price target for Banc of California to $24 from $20 after the bank reported better-than-expected fourth-quarter 2025 earnings. The bank's substantial loan and deposit growth, alongside promising forward guidance and strategic initiatives, support the analyst firm's optimistic projections for profitability and capital…
Jefferies has revised its price target for Abbott Laboratories downward to $145 from $149 after the healthcare company reported fourth-quarter revenue that missed analyst expectations, primarily due to weaker-than-anticipated performance in its Nutrition segment. Abbott’s earnings per share met forecasts, and the company provided guidance for conti…
Jefferies has adjusted its stock price target for McKesson downward to $74 from $79 following the company's underwhelming fourth-quarter earnings and subdued 2026 guidance, attributed mainly to ongoing inflation-related cost pressures. The analyst firm maintains a Buy rating, highlighting McKesson's steady volume expansion, promising innovation eff…
Mizuho has raised its price objective for Nextpower Inc. from $76.00 to $81.00, keeping a Neutral stance on shares that currently trade above this target. The adjustment reflects better credit quality and diversification within the company. Analysts note Nextpower’s solid performance in profitability and cautious management approach, setting expect…
Jefferies has adjusted its price target for Travelers Companies Inc. to $305 from $310, maintaining a Hold rating despite solid quarterly results and raised guidance. The insurer posted earnings and revenue surpassing expectations, underscoring effective operational performance. However, concerns over decelerating business insurance pricing and inc…
Mizuho has adjusted its price target for Intel Corporation to $48 from $41 while retaining a Neutral rating, reflecting a nuanced outlook in light of mixed near-term financial guidance and long-term strategic initiatives. Intel’s shares are trading close to their 52-week peak, having gained over 150% in the past year. The company faces expected rev…
Jefferies has lowered its price target for Inspire Medical Systems to $81 from $100 while maintaining a Hold rating. The adjustment follows a Centers for Medicare & Medicaid Services revision on obstructive sleep apnea coverage, which now entrusts reimbursement decisions to local Medicare Administrative Contractors. This change has reduced upside p…
Jefferies has elevated its price target for Enphase Energy shares to $37, driven by promising contributions from the company's storage hardware business, despite maintaining a Hold rating. The company is expected to exceed fourth-quarter EBITDA estimates partly due to storage hardware, with projections highlighting potential shipment declines in 20…
Raymond James has boosted its price objective for Intuitive Surgical to $615, maintaining a positive stance on the surgical robotics leader after the company delivered stronger-than-expected fourth-quarter earnings and revenue. Despite the stock trading above its fair value based on current metrics, the firm's confidence is bolstered by robust prof…
Barclays has upheld a neutral perspective on the European consumer staples sector but executed a series of targeted rating changes among individual companies. Notably, it upgraded L'Oréal and Haleon to 'overweight' while adjusting price targets across several firms within the food, household, and personal care segments. These modifications reflect …
Lebanese Prime Minister Nawaf Salam revealed that the International Monetary Fund (IMF) has demanded clearer directives in a draft financial rescue law crucial for unlocking funds needed to alleviate the country's devastating six-year financial crisis. The law is designed to distribute losses from the 2019 economic collapse among Lebanon’s financia…
A British junior minister expressed strong disappointment over comments made by U.S. President Donald Trump, who suggested that NATO forces did not participate directly on the frontline in Afghanistan. The minister emphasized the significant casualties sustained by European NATO members supporting American-led missions and defended the alliance's h…
Czechoslovak Group (CSG) debuted on the Euronext Amsterdam stock exchange with a significant market capitalization, reflecting rising investor confidence in the European defense sector amid heightened security concerns post-Russia’s invasion of Ukraine. The company’s IPO attracted strong demand, supported by established ties with key clients such a…
BMO Capital has adjusted its price target for Alcoa to $65 from $67, retaining a Market Perform rating. This action follows Alcoa's recent earnings report which included a one-time CO2 credit benefit rather than operational gains. Despite solid revenue growth and earnings, an extended timeline on asset sales influenced the target revision. Alcoa’s …
RBC Capital has increased its price target on Columbia Banking System to $32 from $30 following the company's fourth-quarter results, which surpassed analyst expectations in earnings per share and revenue. While acquisition-related factors influenced the quarter, core financial indicators such as asset composition, margins, and expense management r…
On January 23, Japanese Finance Minister Satsuki Katayama confirmed close observation of the currency market amid a sudden rise in the yen against the dollar. Although speculation arose regarding rate checks as a precursor to official intervention to support the weakening yen, both Katayama and Vice Finance Minister Atsushi Mimura chose not to comm…
BTIG has adjusted its price target for Capital One Financial from $308 to $270 while retaining a Buy rating following Capital One’s acquisition of Brex. The revision factors in near-term dilution and a projected slowdown in share repurchases, with updated earnings per share (EPS) estimates reflecting these changes. Although Capital One's recent qua…
RBC Capital has increased its price target for Texas Capital Bancshares to $110 from $105 while keeping a Sector Perform rating. The increment follows the company’s solid quarterly performance, robust loan growth, and better-than-expected earnings and revenue in Q4 2025. The stock trades near its 52-week high, supported by significant returns over …
According to Bank of America strategist Michael Hartnett, the typical conditions that indicate a major equity market peak are not fully present in 2026. While investor positioning is high and optimism toward earnings remains robust, the crucial factor of policy tightening is missing. Hartnett emphasizes that without tighter financial conditions, in…
Evercore ISI has lowered its price target for Intuitive Surgical to $550 from $580 while reiterating an "In Line" rating after the company's fourth-quarter earnings report. Intuitive Surgical posted revenue of $2.87 billion, a 19% increase, and strong system placement figures but offered conservative procedure growth projections for fiscal 2026. Th…
Evercore ISI has raised its price target for Vertex Pharmaceuticals to $530 from $475, maintaining an Outperform rating based on the promising commercial potential of povetacicept and confidence in the company's pipeline. Other analysts have also upgraded their outlooks, highlighting favorable clinical data and market dynamics related to Vertex's k…
Evercore ISI has increased its price target on Intel Corporation to $45 from $41.10, retaining an 'In Line' rating despite the stock trading considerably above this level. The adjustment follows Intel's mixed quarterly results, where supply chain issues dampened first-quarter guidance. While the stock experienced a sharp after-hours decline, the co…
Citizens have upheld their Market Outperform rating on Twilio, setting a price target of $185, highlighting the company's robust login metrics and revenue growth. The cloud communications provider's embrace of voice AI agents positions it as a top investment idea for 2026. Similarweb also retains positive rating, reflecting confidence in digital in…
